AVDL
Avadel Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
AVDL Filings
Filing Date
Form Description
Form Type
2025-12-18
Form 8-K - Current report
Key Events
2025-12-18 · Key Events
Form 8-K - Current report
2025-12-09
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2025-12-09 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2025-12-09
Form 8-K - Current report
Key Events
2025-12-09 · Key Events
Form 8-K - Current report
2025-12-03
Form DEFM14A - Definitive proxy statement relating to merger or acquisition
2025-12-03 ·
Form DEFM14A - Definitive proxy statement relating to merger or acquisition
2025-12-02
Form PRER14A - Preliminary Proxy Soliciting materials
2025-12-02 ·
Form PRER14A - Preliminary Proxy Soliciting materials
2025-11-19
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2025-11-19 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2025-11-19
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2025-11-19 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2025-11-19
Form 8-K - Current report
Key Events
2025-11-19 · Key Events
Form 8-K - Current report
2025-11-17
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2025-11-17 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2025-11-17
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2025-11-17 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
